
MSc Chresten Hedegaard
Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies. PV-10, its novel investigational drug for cancer, is designed for injection into solid tumors (intralesional administration), thereby reducing potential for systemic side effects. Its oncology focus in on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dematitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH10 as a topical treatment for atopic dermatitis and psoriasis.
Provectus Biopharmaceuticals, Inc.
CoordinatorMiss Luisa Henk
Drooms is a leading European provider of secure cloud solutions. The software specialist facilitates highly secure access to confidential documents as well as the ability to safely exchange them with third parties beyond company firewalls. Confidential business processes, such as due diligence for funding rounds, license negotiations, M&A activities or protection of intellectual property are handled securely, transparently and efficiently with Drooms.
Headquartered in Frankfurt, Drooms is expanding its global market presence with offices in Munich, London, Paris, Amsterdam, Zug, Madrid, Milan and Vienna. The company is has deep experience facilitating large-scale local and multi-jurisdictional transactions. Their expertise, combined with innovative processes and relentless customer focus have laid the groundwork for Drooms’ excellent reputation.

Drooms
Senior Manager Business DevelopmentJan Hoffmeister
Drooms is a leading European provider of secure cloud solutions. The software specialist facilitates highly secure access to confidential documents as well as the ability to safely exchange them with third parties beyond company firewalls. Confidential business processes, such as due diligence for funding rounds, license negotiations, M&A activities or protection of intellectual property are handled securely, transparently and efficiently with Drooms.
Headquartered in Frankfurt, Drooms is expanding its global market presence with offices in Munich, London, Paris, Amsterdam, Zug, Madrid, Milan and Vienna. The company is has deep experience facilitating large-scale local and multi-jurisdictional transactions. Their expertise, combined with innovative processes and relentless customer focus have laid the groundwork for Drooms’ excellent reputation.
